Chao‐Kai Chou

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Shiping Jiao, Weiya Xia, Hirohito Yamaguchi et al. · Clinical Cancer Research · 2017 · 943 citations · Full text

Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Chao‐Kai Chou, Thomas J. Dull, David Russell et al. · Journal of Biological Chemistry · 1987 · 648 citations · Full text

Insulin Signaling, Molecular Pharmacology, Insulin Delivery +21

IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

Dung‐Fang Lee, Hsu-Ping Kuo, Chun‐Te Chen et al. · Cell · 2007 · 625 citations · Full text

Inflammation, Signal Transduction, Signaling Pathway +10

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung et al. · Cancer Cell · 2018 · 590 citations · Full text

Breast Oncology, Medicine, Immunology +8

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Ri‐Yao Yang, Linlin Sun, Ching-Fei Li et al. · Nature Communications · 2021 · 561 citations · Full text